Occupational exposure and radiobiological risk from thyroid radioiodine therapy in Saudi Arabia

Abstract Worldwide, thyroid cancer accounts for some 10% of total cancer incidence, most markedly for females. Thyroid cancer radiotherapy, typically using 131I (T1/2 8.02 days; β− max energy 606 keV, branching ratio 89.9%), is widely adopted as an adjunct to surgery or to treat inoperable cancer an...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: H. I. Al-Mohammed, A. Sulieman, Fareed H. Mayhoub, Hassan Salah, Celestino Lagarde, M. Alkhorayef, Ali Aldhebaib, C. Kappas, D. A. Bradley
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/53d14499c8984c2ab7ded3ab28ce9a00
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!